s6y
Company name or ticker
Search
Denali Therapeutics Inc.
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filed
Friday, October 27, 2017
Accession number
0000950123-17-009295
Documents
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS/A
Exhibits
10
Material contract
EX-10
10
Material contract
EX-10
On sec.gov
Filing index
All files
Complete submission text
SGML header